Armata Pharmaceuticals Inc (ARMP)
2.41
+0.01
(+0.42%)
USD |
NYAM |
May 02, 16:00
2.41
0.00 (0.00%)
After-Hours: 17:52
Armata Pharmaceuticals Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.305M |
June 30, 2017 | 0.606M |
March 31, 2017 | 0.598M |
December 31, 2016 | 0.803M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.00 |
Date | Value |
---|---|
June 30, 2008 | 0.335M |
March 31, 2008 | 0.335M |
December 31, 2007 | 0.336M |
September 30, 2007 | 0.504M |
June 30, 2007 | 1.678M |
March 31, 2007 | 1.683M |
December 31, 2006 | 1.699M |
September 30, 2006 | 8.197M |
June 30, 2006 | 8.221M |
March 31, 2006 | 8.277M |
December 31, 2005 | 8.332M |
September 30, 2005 | 8.385M |
June 30, 2005 | 10.94M |
March 31, 2005 | 11.11M |
December 31, 2004 | 11.30M |
September 30, 2004 | 11.58M |
June 30, 2004 | 12.38M |
March 31, 2004 | 12.32M |
December 31, 2003 | 12.52M |
September 30, 2003 | 12.67M |
June 30, 2003 | 22.10M |
March 31, 2003 | 22.11M |
December 31, 2002 | 21.79M |
September 30, 2002 | 23.74M |
June 30, 2002 | 23.12M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
AIM ImmunoTech Inc | 0.00 |
Perspective Therapeutics Inc | 1.725M |
Protalix BioTherapeutics Inc | 20.25M |
Electromed Inc | 0.00 |
Xtant Medical Holdings Inc | 21.79M |